Replay
10 second
10 second
Annotation
00:00 / 00:00
  • Report playback issue
  • Copy video URL
  • Copy video URL at current time
  • Copy embed html
  • NDTV Player Version : 3.7.1
  • © Copyright NDTV Convergence Ltd. 2025

Glenmark’s diabetic slowdown

Glenmark has chosen to stay away from investing in diabetes research until it manages to find a partner as the cost of developing a cure for diabetes, said Glenn Saldanha, MD & CEO, Glenmark Pharma.

Related Videos